Harjyot Sohal, MD
Critical Care Medicine · Osage Beach, MONPI 1962468520
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,346 of the $10,243 with a category attached, or 62.0%. 37 manufacturers reported payments, led by Pulmonx Corporation at 40.8% of the total. Reporting peaked in 2024 at $3,563 and has fallen 74.2% since, to $919 in 2025. Among critical care medicine clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 373 payments — averaging $27.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pulmonx Corporation$4K
- AstraZeneca$1K
- Boehringer Ingelheim$1K
- GSK$784
- Regeneron Healthcare Solutions, Inc.$530
- Sanofi$347
- plus $2K from 31 others
What the payments were for
- Consulting fees$2,71326%
- Travel & lodging$1,16211%
- Food & beverage$6,34662%
- Education$220%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pulmonx Corporation | 11 | $4,184 |
| AstraZeneca | 61 | $1,112 |
| Boehringer Ingelheim | 65 | $1,075 |
| GSK | 55 | $784 |
| Regeneron Healthcare Solutions, Inc. | 28 | $530 |
| Sanofi | 20 | $347 |
| Electromed, Inc. | 16 | $270 |
| Sunovion Pharmaceuticals Inc. | 13 | $257 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $203 |
| Mylan Specialty L.p. | 13 | $195 |
| Grifols USA, LLC | 9 | $166 |
| Genentech USA, Inc. | 13 | $157 |
| AbbVie(2 entities) | 8 | $116 |
| Verona Pharma, Inc. | 4 | $74 |
| United Therapeutics Corporation | 3 | $63 |
| Novartis | 3 | $59 |
| Viatris Specialty LLC | 3 | $58 |
| Merck | 3 | $56 |
| Apria Healthcare LLC | 2 | $55 |
| Actelion Pharmaceuticals US, Inc. | 3 | $52 |
| Circassia Inc. | 3 | $46 |
| Shire North American Group Inc | 2 | $42 |
| Bio Products Laboratory USA, Inc. | 2 | $38 |
| Pfizer | 2 | $38 |
| CSL Behring | 1 | $36 |
| Bard Peripheral Vascular, Inc. | 1 | $34 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Masimo Corporation | 1 | $22 |
| Insmed, Inc. | 1 | $21 |
| Baxter Healthcare | 1 | $19 |
| Resmed Corp | 1 | $18 |
| Hospira, Inc. | 1 | $16 |
| Tanabe Pharma America, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Advanced Respiratory, Inc | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| ADMA Biomanufacturing LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,243 in reported general payments places this provider in the 95th percentile of 208 critical care medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 78 | $1,031,274 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 448 | $382,197 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 358 | $305,497 |
| NucalaMepolizumab | 69 | $259,872 |
| Spiriva RespimatTiotropium Bromide | 217 | $152,162 |
| Gammagard S-DImmun Glob G/Gly/Gluc/Iga 0-50 | 12 | $132,427 |
| Pirfenidone | 22 | $126,949 |
| CuvitruImmun Glob G(Igg)/Gly/Iga Ov50 | 22 | $93,062 |
| Breo ElliptaFluticasone/Vilanterol | 161 | $85,960 |
| SymbicortBudesonide/Formoterol Fumarate | 275 | $80,275 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 106 | $74,311 |
| Dupixent PenDupilumab | 14 | $54,306 |
| Incruse ElliptaUmeclidinium Bromide | 100 | $41,267 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 44 | $28,673 |
| Advair HfaFluticasone Propion/Salmeterol | 44 | $22,832 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat, Combivent Respimat | $1,075 | $1,270,893420 claims |
| GSKTrelegy Ellipta, Nucala, Breo Ellipta, Incruse Ellipta, Anoro Ellipta | $784 | $821,377916 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $1,112 | $396,835657 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Cuvitru | $203 | $93,06222 claims |
| PfizerEliquis | $38 | $11,11317 claims |
| MerckDulera | $56 | $7,88519 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 208 critical care medicine providers in Missouri.
Other critical care medicine in Osage Beach
- Harbaksh SanghaOsage Beach$567
- Jacob KeepermanSaint Louis$51K
- Farid SadakaSaint Louis$41K
- Rajat DharSaint Louis$31K
- Pratik SinhaSaint Louis$25K
- Bryan KraftSaint Louis$24K
- Yuji ObaColumbia$14K
- Tinashe MadukeColumbia$13K
- Stephanie WhitbeyColumbia$12K
- Adam MaySaint Louis$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.